Teelen K - Search Results

1

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes.

Fabra-García A, Hailemariam S, de Jong RM, Janssen K, Teelen K, van de Vegte-Bolmer M, van Gemert GJ, Ivanochko D, Semesi A, McLeod B, Vos MW, de Bruijni MHC, Bolscher JM, Szabat M, Vogt S, Kraft L, Duncan S, Kamya MR, Feeney ME, Jagannathan P, Greenhouse B, Dechering KJ, Sauerwein RW, King CR, MacGill RS, Bousema T, Julien JP, Jore MM. Fabra-García A, et al. Among authors: teelen k. Immunity. 2023 Feb 14;56(2):406-419.e7. doi: 10.1016/j.immuni.2023.01.009. Immunity. 2023. PMID: 36792574 Free PMC article.

2

Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.

Roeffen W, Beckers PJ, Teelen K, Lensen T, Sauerwein RW, Meuwissen JH, Eling W. Roeffen W, et al. Among authors: teelen k. Exp Parasitol. 1995 Feb;80(1):15-26. doi: 10.1006/expr.1995.1003. Exp Parasitol. 1995. PMID: 7529717 Free article.

3

Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48/45 and Pfs230 in field sera.

Roeffen W, Lensen T, Mulder B, Teelen K, Sauerwein R, Eling W, Meuwissen JH, Beckers P. Roeffen W, et al. Among authors: teelen k. Mem Inst Oswaldo Cruz. 1994;89 Suppl 2:13-5. doi: 10.1590/s0074-02761994000600004. Mem Inst Oswaldo Cruz. 1994. PMID: 7565122 Free article.

4

Comparison of serological tests and bio-assay for malaria transmission blocking capacity in field sera.

Roeffen W, Beckers PJ, Teelen K, Verhave JP, Eling W, Sauerwein R. Roeffen W, et al. Among authors: teelen k. Parassitologia. 1993 Jul;35 Suppl:95-7. Parassitologia. 1993. PMID: 7694226

5

A comparison of transmission-blocking activity with reactivity in a Plasmodium falciparum 48/45-kD molecule-specific competition enzyme-linked immunosorbent assay.

Roeffen W, Lensen T, Mulder B, Teelen K, Sauerwein R, Van Druten J, Eling W, Meuwissen JH, Beckers PJ. Roeffen W, et al. Among authors: teelen k. Am J Trop Med Hyg. 1995 Jan;52(1):60-5. doi: 10.4269/ajtmh.1995.52.60. Am J Trop Med Hyg. 1995. PMID: 7856826 Free article.

6

Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon.

Roeffen W, Mulder B, Teelen K, Bolmer M, Eling W, Targett GA, Beckers PJ, Sauerwein R. Roeffen W, et al. Among authors: teelen k. Parasite Immunol. 1996 Feb;18(2):103-9. doi: 10.1046/j.1365-3024.1996.d01-54.x. Parasite Immunol. 1996. PMID: 9223163

7

Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen.

Roeffen W, Teelen K, van As J, vd Vegte-Bolmer M, Eling W, Sauerwein R. Roeffen W, et al. Among authors: teelen k. Exp Parasitol. 2001 Jan;97(1):45-9. doi: 10.1006/expr.2000.4586. Exp Parasitol. 2001. PMID: 11207113 No abstract available.

8

Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum.

Roeffen WF, Raats JM, Teelen K, Hoet RM, Eling WM, van Venrooij WJ, Sauerwein RW. Roeffen WF, et al. Among authors: teelen k. J Biol Chem. 2001 Jun 8;276(23):19807-11. doi: 10.1074/jbc.M100562200. Epub 2001 Feb 23. J Biol Chem. 2001. PMID: 11279092 Free article.

9

Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia.

Bousema JT, Roeffen W, van der Kolk M, de Vlas SJ, van de Vegte-Bolmer M, Bangs MJ, Teelen K, Kurniawan L, Maguire JD, Baird JK, Sauerwein RW. Bousema JT, et al. Among authors: teelen k. Am J Trop Med Hyg. 2006 Mar;74(3):425-31. Am J Trop Med Hyg. 2006. PMID: 16525101 Free article.

10

Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.

Hermsen CC, Verhage DF, Telgt DS, Teelen K, Bousema JT, Roestenberg M, Bolad A, Berzins K, Corradin G, Leroy O, Theisen M, Sauerwein RW. Hermsen CC, et al. Among authors: teelen k. Vaccine. 2007 Apr 12;25(15):2930-40. doi: 10.1016/j.vaccine.2006.06.081. Epub 2006 Aug 2. Vaccine. 2007. PMID: 16914240 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page